EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of the Glycosaminoglycan Metabolism‐Related Protein IDUA Associated With Tumor Progression and Prognosis in ccRCC

Zhangjun Cao, Songbai Yan, Wenhao Chu, Haichao Yuan, Zefeng Shen, Liangkuan Bi, Longfei Peng iD

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 09.11.2026. Verfasst von Zhangjun Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Biomarkers, Tumor, Kidney Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Funding of Shenzhen Clinical Research Center for Urology and Nephrology, Shenzhen High-level Hospital Construction Fund, Peking University Shenzhen Hospital Scientific Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study investigated the expression, prognostic significance, and functional role of α‐L‐iduronidase (IDUA) in clear cell renal cell carcinoma (ccRCC).

Methods

We performed two‐sample Mendelian randomization using eQTL and ccRCC GWAS data. We analyzed transcriptomic and clinical data from TCGA and GEO cohorts. We constructed a prognostic nomogram integrating IDUA expression with clinicopathological variables. We used ESTIMATE and CIBERSORT algorithms to evaluate immune infiltration and examined correlations between IDUA and immune checkpoint genes. We knocked down IDUA in 786‐O and ACHN cells using shRNA and assessed proliferation, invasion, and migration via MTT, Transwell, and wound‐healing assays.

Results

IDUA was significantly overexpressed in ccRCC tumors versus normal tissues. High IDUA expression correlated with advanced stage, higher T stage, and poor overall survival. Multivariate Cox regression confirmed IDUA as an independent prognostic factor (HR = 1.614, p < 0.001). The nomogram showed good predictive performance for 1‐, 3‐, and 5‐year survival. IDUA expression positively correlated with immune checkpoint genes (PDCD1, CD274, CTLA4) and with infiltration of CD8+ T cells, Tregs, and activated NK cells. High IDUA predicted higher Immunophenoscores, suggesting better immunotherapy response. In vitro, IDUA knockdown significantly reduced ccRCC cell proliferation, invasion, and migration.

Conclusion

IDUA serves as an independent prognostic biomarker in ccRCC, promotes tumor aggressiveness, and may modulate the immune microenvironment. These findings support IDUA as a potential therapeutic target and a candidate predictor for immunotherapy response in ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellBiomarkers, TumorKidney NeoplasmsHumansPrognosisDisease ProgressionGene Expression Regulation, NeoplasticFemaleCell ProliferationCell Line, TumorMaleCell Movement

Stichwörter der Autor:innen

clear cell renal cell carcinoma (ccRCC)glycosaminoglycans (GAGs)therapeutic targettumor microenvironment (TME)α‐L‐iduronidase (IDUA)

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Shenzhen Clinical Research Center for Urology and Nephrology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Department of Urology, Peking University Shenzhen Hospital Xinhua Campus (Shenzhen Xinhua Hospital), Shenzhen, China.
  • Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen, China.
  • The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

ORCID-Profile: Longfei Peng

Förderung

  • Funding of Shenzhen Clinical Research Center for Urology and Nephrology
  • Shenzhen High-level Hospital Construction Fund
  • Peking University Shenzhen Hospital Scientific Research Fund

Zitieren

APA

Cao, Z., Yan, S., Chu, W., Yuan, H., Shen, Z., Bi, L., & Peng, L. (2026). Identification of the Glycosaminoglycan Metabolism‐Related Protein IDUA Associated With Tumor Progression and Prognosis in ccRCC. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72347

Vancouver

Cao Z, Yan S, Chu W, Yuan H, Shen Z, Bi L, et al. Identification of the Glycosaminoglycan Metabolism‐Related Protein IDUA Associated With Tumor Progression and Prognosis in ccRCC. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72347

BibTeX
@article{Cao2026,
  author = {Cao, Zhangjun and Yan, Songbai and Chu, Wenhao and Yuan, Haichao and Shen, Zefeng and Bi, Liangkuan and Peng, Longfei},
  title = {Identification of the Glycosaminoglycan Metabolism‐Related Protein IDUA Associated With Tumor Progression and Prognosis in ccRCC},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72347}
}
Kostenlos starten →